Abercrombie & Fitch cut from Conviction Buy List at Goldman
ANF was removed from the Conviction Buy list, Goldman Sachs said. Valuation call, as the stock is up 32% over the past 11 months.
-----
Aeropostale upgraded at Goldman
ARO was upgraded from Sell to Neutral, Goldman Sachs said. The company can expand margins in the coming quarter.
-----
American Tower numbers adjusted at Citigroup
Shares of AMT now seen reaching $65, according to Citigroup. Estimates lowered on FX headwinds. Buy rating.
-----
American Tower estimates, target raised at JP Morgan
Shares of AMT now seen reaching $62, according to JP Morgan. Estimates also increased on Core and Sprint MLA.
-----
AmerisourceBergen estimates increased at UBS
ABC estimates increased through 2013, UBS said. Positive operating trends. Maintain $47 price target and Buy rating.
-----
Ann downgraded at Goldman
ANN was downgraded from Neutral to Sell, Goldman Sachs said. Margins are peaking and the company is leveraged to slower macro growth.
-----
Archer Daniels Midland numbers cut at Morgan Stanley
Shares of ADM now seen reaching $37, according to Morgan Stanley. Estimates also reduced, given lower oilseed margins. Overweight rating.
-----
Atmel downgraded at Needham
ATML was downgraded from Strong Buy to Buy, Needham said. Company could face inventory rebalancing in the next couple of quarters.
-----
Autodesk target cut at UBS
ADSK target lowered to $43, UBS said. VARs continue to plod through a sluggish economic environment. Buy rating.
-----
Baker Hughes numbers cut at Credit Suisse
Shares of BHI now seen reaching $80, according to Credit Suisse. Estimates also reduced, given lower expected North American pricing. Outperform rating.
-----
Baker Hughes estimates increased at Sterne Agee
BHI estimates raised through 2012, Sterne Agee said. Bullish rig count forecast. Maintain $71 price target and Buy rating.
-----
Baker Hughes estimates, target cut at UBS
Shares of BHI now seen reaching $82, according to UBS. Estimates also increased as overall story is still in on track despite a sloppy 3Q. Buy rating.
-----
Catalyst Health numbers lowered at Credit Suisse
Shares of CHSI now seen reaching $62, according to Credit Suisse. Estimates also cut, to match the company's new guidance. Outperform rating.
-----
Caterpillar rated new Overweight at Morgan Stanley
CAT was initiated with an Overweight rating, Morgan Stanley said. Valuation call, based on a $125 price target.
-----
CME Group numbers lowered at Jefferies
CME estimates were cut through 2012, Jefferies said. Volume has moderates and expenses could be back on the rise. Buy rating and new $297 price target.
-----
CME Group estimates lowered at UBS
CME estimates lowered through 2012, UBS said. MF Global bankruptcy may be a blow to the futures industry as a whole. Buy rating.
-----
Corning downgraded at JP Morgan
GLW was downgraded from Neutral to Underweight, JP Morgan said. Consumer risks are mounting.
-----
Deere rated new Underweight at Morgan Stanley
Coverage of DE was started with an Underweight rating, Morgan Stanley said. Company faces slower growth and margin pressures. $74 price target.
-----
Diamond Foods downgraded at BofA/Merrill
DMND was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. $65 price target. Estimates also cut, as the Pringles acquisition has been delayed.
-----
Discovery Communications numbers increased at UBS
Shares of DISCA now seen reaching $43, according to UBS. Estimates also raised as Netflix deal more accretive than expectations. Neutral rating.
-----
Emerson Electric target increased at UBS
EMR target increased to $51, UBS said. Positive outlook despite challenging macro. Maintain Neutral rating.
-----
Emerson Electric estimates, target cut at Sterne Agee
Shares of EMR now seen reaching $54, according to Sterne Agee. Estimates also lowered on slower expected global growth. Neutral rating.
-----
EOG Resources estimates increased at UBS
EOG estimates increased through 2012, UBS said. 3Q beats on higher than expected natural gas and NGL production. Neutral rating.
-----
Fidelity estimates, target lowered at Oppenheimer
FIS estimates were cut through 2012, Oppenheimer said. EBITDA growth is slowing. Outperform rating and new $32 price target.
-----
FXCM upgraded at Citigroup
FXCM was upgraded from Sell to Neutral, Citigroup said. $11.25 price target. With the recent downdraft we see a more balanced risk/reward.
-----
HCA estimates, target raised at Credit Suisse
Shares of HCA now seen reaching $27, according to Credit Suisse. Estimates also increased, given solid volume growth and cost cuts. Outperform rating.
-----
Impax Laboratories numbers cut at Goldman
Shares of IPXL now seen reaching $18, according to Goldman Sachs. Estimates also reduced, given lower expected Adderall XR sales. Sell rating.
-----
Intrepid Potash rated new Neutral at UBS
IPI was initiated with a Neutral rating, UBS said. $28 price target. Significant growth, but at a fair price.
-----
IPG Photonics upgraded at Needham
IPGP was upgraded from Hold to Buy, Needham said. $60 price target. Company has solid visibility.
-----
Lamar Advertising numbers cut at Benchmark
Shares of LAMR now seen reaching $18, according to Benchmark. Estimates also reduced, as the outdoor advertising market has stalled. Hold rating.
-----
MEMC Electronic Materials numbers lowered at Citigroup
Shares of WFR now seen reaching $10, according to Citigroup. Estimates also lowered on softer wafer volumes/pricing. Buy rating.
-----
MetroPCS Communications estimates lowered at Citigroup
PCS estimates lowered through 2012, Citigroup said. Smartphone strategy may be misaligned with its historical success as a low cost provider. Neutral rating.
-----
MetroPCS upgraded at JP Morgan
PCS was upgraded from Neutral to Overweight, JP Morgan said. Better than expected 3Q11 subscriber performance which sets a base line for the business in its typically weakest quarter.
-----
Monsanto rated new Neutral at UBS
MON was initiated with a Neutral rating, UBS said. $72 price target. Stock valuation stretched to the limit.
-----
Myriad Genetics upgraded at Ticonderoga
MYGN was upgraded from Neutral to Buy, Ticonderoga said. $25 price target. BRAC Analysis continues to perform well.
-----
NII Holdings estimates, target cut at Citigroup
Shares of NIHD now seen reaching $45, according to Citigroup. Estimates also lowered on 3G opex costs. Buy rating.
-----
Nike upgraded at Goldman
NKE was upgraded from Neutral to Buy, Goldman Sachs said. Company was also added to the Conviction List. Stock usually performs well in an Olympic year.
-----
OpenTable downgraded at BofA/Merrill
OPEN was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $48 price target.
-----
OpenTable downgraded at Morgan Keegan
OPEN was downgraded from Outperform to Market Perform, Morgan Keegan aid. $39 price target. Slower macro growth could weigh on earnings.
-----
OpenTable estimates, target cut at Citigroup
Shares of OPEN now seen reaching $67, according to Citigroup. Estimates also lowered on removal of spotlight revenue and restaurant industry macro weakness. Buy rating.
-----
OpenTable estimates, target reduced at Oppenheimer
Shares of OPEN now seen reaching $54, according to Oppenheimer. Estimates also cut, given slower realized growth. Outperform rating.
-----
Oshkosh Truck upgraded at Benchmark
OSK was upgraded from Hold to Sell, Benchmark said. $20 price target. Consensus expectations have come down to a reasonable level.
-----
Oshkosh downgraded at Sterne Agee
OSK was downgraded from Neutral to Underperform, Sterne Agee said. $16 price target. Defense business remains weak and it will likely be another year of transition for the commercial division.
-----
Pinnacle West estimates increased at UBS
PNW estimates increased through 2011, UBS said. AZ Sun plan continues to gain traction. Maintain $45 price target and Neutral rating.
-----
Praxair downgraded at Argus
PX was downgraded from Buy to Hold, Argus Research said. Valuation call.
-----
Ritchie Bros. upgraded at Baird
RBA was upgraded from Neutral to Outperform, Robert Baird said. $25 price target. Earnings should bounce back in the fourth quarter, due to a calendar shift.
----
Rowan estimates, target reduced at Jefferies
RDC estimates were cut through 2012, Jefferies said. Company is facing higher costs. Buy rating and new $48 price target.
-----
SM Energy numbers cut at Jefferies
Shares of SM now seen reaching $110, according to Jefferies. Estimates also reduced, as growth is slowing outside of Eagle Ford. Buy rating.
-----
Tenet Healthcare numbers boosted at Credit Suisse
Shares of THC now seen reaching $6, according to Credit Suisse. Estimates also upped, given higher expected near-term growth. Outperform rating.
-----
Texas Roadhouse downgraded at Credit Suisse
TXRH was downgraded from Outperform to Neutral, Credit Suisse said. $16.50 price target. Company has limited pricing power.
-----
Thoratec estimates increased at UBS
THOR estimates lowered through 2012, UBS said. Guidance elevated on margins. Maintain $39 price target and Buy rating.
-----
Treehouse Foods downgraded at Wells
THS was downgraded from Outperform to Market Perform, Wells Fargo said. Valuation call.
-----
Triumph estimates, target raised at Credit Suisse
Shares of TGI now seen reaching $68, according to Credit Suisse. Estimates also increased, as the company remains leveraged to the aerospace cycle. Outperform rating.
-----
Under Armour upgraded at Goldman
UAUA was upgraded from Neutral to Buy, Goldman Sachs said. Brand momentum can help drive margin growth.
-----
US Cellular downgraded at Morgan Stanley
USM was downgraded from Equal-weight to Underweight, Morgan Stanley said. $35 price target. Company is facing increased competition.
-----
Westlake Chemical estimates cut at UBS
WLK estimates lowered through 2012, UBS said. Margin squeeze on polyolefins. Maintain $45 price target and Neutral rating.
